ISRCTN28592111已完成未知
The effect of glycopyrronium bromide on hypersalivation in patients with Parkinson's disease: a randomised, cross-over, double blind, placebo-controlled trial
Hospital Medisch Spectrum Twente (The Netherlands)0 个研究点目标入组 23 人开始时间: 2007年2月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
2010 results in https://pubmed.ncbi.nlm.nih.gov/20385892/ (added 15/01/2021)
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with Parkinson's disease
- •2. Aged more than or equal to 18 years
- •3. Hypersalivation score more than or equal to five (on a scale from one to nine)
- •4. Patient or family is able to score the extent of hypersalivation
排除标准
- •1. Hypersensitivity to glycopyrronium bromide, sorbic acid or saccharin sodium
- •2. Myasthenia gravis
- •3. Symptomatic tachycardia
- •4. Coronary insufficiency
- •5. Heart rhythm disorders
- •6. Glaucoma
- •7. Pylorus stenosis
- •8. Paralytic ileus
- •9. Prostate hypertrophy
- •10 Patients using potassium chloride tablets, oral digoxin or oral corticosteroids
- •11. Kidney function disorders
- •12. Pregnancy or lactation
研究者
相似试验
已完成
2 期
The effect of glycopyrronium bromide on hypersalivation in patients with Parkinson's disease: a randomised, cross-over, double-blind, placebo controlled trial.NL-OMON30532Medisch Spectrum Twente24
已完成
不适用
The effect of glycopyrroniumbromide on hypersalivation in patients with Parkinson's disease: a randomised, cross-over, doubleblind, placebocontrolled trial.Parkinsonian patients with hypersalivationNL-OMON20228M.E.L. Arbouw, Hospital Medisch Spectrum TwenteDepartment of clinical pharmacyP.O. Box 50.0007500 KA EnschedeThe Netherlands24
已完成
不适用
Clofibrate in ictereonatal jaundice.Neonatal jaundice, unspecifiedIRCT201008172639N3Shaheed Sadoughi University of Medical Sciences and Health Services60
已完成
4 期
Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary DiseaseNCT01922271Novartis Pharmaceuticals152
已完成
2 期
The effect of INhaled Glycopyrronium bromide on Excessive Sialorrhea and Drooling in Parkinson disease: a dose finding studyNL-OMON45524Medisch Spectrum Twente10
